Agent Orange, Esophageal Cancer and Barrett’s Esophagus

Just because the VA says there’s no presumption of a connection between Agent Orange exposure and esophageal cancer doesn’t mean you can’t win benefits for this disability. With the right evidence, esophageal cancer can still be linked directly to Agent Orange or claimed as secondary to another condition that’s already service connected.

• Veterans exposed to herbicide can use direct service connection (with a medical nexus) or claim esophageal cancer as secondary to an Agent Orange presumptive illness like hypertension or to service-connected GERD and Barrett’s esophagus.
• Esophageal cancer is rated at 100% during the treatment phase and 6 months after treatment under Diagnostic Code 7343; then the VA re-rates the lasting effects (residuals).
• Residuals are rated from 0 to 80% under DC 7203 (esophageal stricture) and 10% or 30% under DC 7207 (Barrett’s without stricture).
• Even if the VA initially denies or underrates esophageal cancer and its complications, strong evidence and the correct legal path can help win and maximize compensation.

Is Esophageal Cancer an Agent Orange Presumptive Condition?

Esophageal cancer is not currently recognized as an Agent Orange presumptive condition under 38 C.F.R. § 3.309(e). However, veterans exposed to Agent Orange who have esophageal cancer may still qualify for a VA rating by establishing a direct or secondary service connection.

Does the PACT Act Cover Esophageal Cancer?

While the PACT Act did not add esophageal cancer to the list of presumptive Agent Orange condition, it made it presumptive for veterans with other qualifying exposures: burn pits and radiation.

Presumptive Exposure for Esophageal Cancer

1. Burn Pits and Airborne Hazards: Under the PACT Act, gastroesophageal cancers, including esophageal cancer, are recognized as presumptive conditions for many veterans who served in qualifying Gulf War and post-9/11 toxic exposure locations.
2. Ionizing Radiation Exposure: Esophageal cancer is recognized under the PACT Act as a condition for some “Atomic Veterans” who participated in radiation-risk activities, such as nuclear weapons testing or designated cleanup operations.

Agent Orange Claims Follow Different Rules

While a post-9/11 veteran with qualifying burn pit exposure may be eligible through a presumptive route, a Vietnam veteran exposed to Agent Orange generally must prove the connection with medical evidence and a well-supported nexus opinion.

However, for Agent Orange itself, the PACT Act expanded the presumptive list by adding conditions such as hypertension. Because hypertension is now presumptive, it can anchor a secondary claim for esophageal cancer (although this would require a strong, case-specific medical opinion explaining causation or aggravation).

How Does the VA Rate Esophageal Cancer?

Esophageal cancer VA disability ratings vary depending on the disease status and residuals. When veterans are in the active cancer treatment phase, the condition is rated at 100% under DC 7343. The 100% rating continues during treatment and for six months after treatment ends.

A mandatory re-examination is done once the six-month post-treatment period is over. This re-exam involves getting a new rating for the cancer residuals (symptoms that exist from cancer or cancer treatment, such as chemotherapy, after treatment is over).

The most common residual of esophageal cancer is esophageal stricture (DC 7203), with ratings ranging from 0 to 80%, based on symptoms such as swallowing difficulty and required treatment modalities. The VA may also use DC 7207 (Barrett’s esophagus without stricture) or other diagnostic codes.

DC 7203 Ratings for Esophageal Cancer Residuals

Criteria (esophageal stricture)	VA rating	Monthly compensation (veteran alone)
Recurrent or refractory stricture causing dysphagia with aspiration, undernutrition, or substantial weight loss, and treated by surgical correction or PEG tube	80%	$2,102.15
Stricture causing dysphagia requiring dilatation 3+ times/year, steroid dilatation 1+ time/year, or esophageal stent	50%	$1,132.90
Recurrent stricture causing dysphagia requiring dilatation no more than 2 times/year	30%	$552.47
Stricture requiring daily medication to control dysphagia, otherwise asymptomatic	10%	$180.42
Documented history without daily symptoms or daily medication	0%	$0.00

Higher compensation is available for veterans with a spouse, dependent children, and, in some situations, dependent parents.

DC 7207 VA Ratings (Barrett’s esophagus without stricture)

Criteria under DC 7207	VA rating
Documented by pathologic diagnosis with high-grade dysplasia	30%
Documented by pathologic diagnosis with low-grade dysplasia	10%

Some veterans could qualify for Total Disability Based on Individual Unemployability (TDIU). TDIU allows payment at the 100% rate when service-connected conditions prevent substantially gainful employment, even when the combined disability rating is less than 100%.

What Residuals Matter After Treatment?

Residuals are the medical problems that remain after cancer treatment ends. These ongoing effects may result from the cancer itself or from treatments such as surgery, chemotherapy, or radiation therapy. Common esophageal residuals include:

• Chronic fatigue
• Difficulty swallowing
• Nerve damage (neuropathy)
• Scar formation
• Digestive problems
• Injury to nearby organs
• Esophageal treatment modalities.

Specific residuals that matter most during the post-treatment re-evaluation rating phase include objective symptoms or treatments that result in a higher post-treatment VA rating; these include:

• Dysphagia (difficulty swallowing)
• Esophageal stricture
• Esophageal dilations, stent, used to manage stricture
• A PEG tube (feeding tube)
• Aspiration
• Undernutrition (substantial weight loss)
• Chronic reflux
• Barrett’s esophagus

Difficulty swallowing (dysphagia) and esophageal strictures, both rated under DC 7203, are among the most common long-term effects of esophageal cancer and its treatment. The VA ties the rating to how often dilation is needed and whether there is a stent, feeding tube, aspiration, undernutrition, or significant weight loss.

What Types of Esophageal Cancer Are Linked to Agent Orange?

Esophageal cancer occurs in two primary forms. Adenocarcinoma is the type most often associated with Agent Orange exposure. This type of cancer usually develops in the lower portion of the esophagus and is linked with chronic acid reflux and Barrett’s esophagus (a condition involving abnormal tissue changes in the esophageal lining).

A second type of esophageal cancer called squamous cell carcinoma begins in the flat cells that line the inside of the esophagus. This form is more strongly linked to risk factors such as tobacco use and heavy alcohol consumption.

A 2015 research study, conducted by the American College of Gastroenterology showed that Vietnam veterans exposed to Agent Orange had approximately twice the likelihood of developing esophageal adenocarcinoma compared with veterans who were not exposed.

How Are Barrett’s Esophagus and GERD Connected to Esophageal Cancer?

Chronic gastrointestinal reflux disease (GERD) damages the lining of the esophagus (the tube that carries food from the mouth to the stomach) and can lead to a condition called Barrett’s esophagus.

Over time, normal esophageal cells can be replaced by abnormal cells. In some instances, these abnormal changes may progress to adenocarcinoma. Although some people with Barrett’s esophagus never develop cancer, studies show Barrett’s carries approximately a 30 to 60 times higher relative risk of esophageal adenocarcinoma.

GERD, Barrett’s and Esophageal Stricture Ratings

The VA evaluates GERD, Barrett’s esophagus, and esophageal strictures as separate conditions with different rating criteria (all rated under 38 C.F.R. § 4.114), if each diagnosis causes distinct, non-overlapping impairment or symptoms. The assigned diagnostic code depends on the specific symptoms or complications causing the impairment.

• Acid reflux symptoms: When the primary problems are heartburn, stomach acid backing into the throat, or regurgitation, the VA usually rates the condition under DC 7206 (GERD).
• Abnormal cell changes: When a biopsy shows precancerous tissue changes in the esophagus without a narrowing, the VA generally assigns DC 7207 (Barrett’s esophagus).
• Esophageal narrowing: If scar tissue causes the esophagus to become constricted, making it difficult for food or liquids to pass normally, the VA typically evaluates the condition under DC 7203 (esophageal stricture).

If GERD is already service-connected, Barrett’s esophagus, and any adenocarcinoma that develops as a result of Barrett’s can be claimed as a secondary service-connected condition under 38 C.F.R. § 3.310.

How to Establish Service Connection for Esophageal Cancer

Veterans can establish service connection for esophageal cancer in two ways: directly, by linking the cancer to Agent Orange exposure with a medical nexus, or secondarily, by linking the condition to a disorder the VA already recognizes.

1. Direct service connection pathway – provide a current esophageal cancer diagnosis, proof of Agent Orange or other herbicide, or toxic exposure, and a strong nexus opinion explaining that the cancer is “at least as likely as not” related to Agent Orange exposure.
2. Secondary service connection pathway– provide a current esophageal cancer diagnosis and link the cancer to a current service-connected condition, such as GERD, Barrett’s esophagus, or chronic hypertension (which may affect how cells grow and function within the body). Research, including a nationwide population-based study, discovered that uncontrolled hypertension was associated with a higher risk of developing esophageal cancer.

If GERD is service-connected, and the medical record shows progression from GERD to Barrett’s esophagus to esophageal adenocarcinoma, a secondary service-connection theory may be stronger than an Agent Orange direct-causation theory.

What Evidence Helps Win a Non-Presumptive Esophageal Cancer Claim?

Because esophageal cancer is not a presumptive Agent Orange disorder, the strength of a winning disability claim depends heavily on the quality of evidence submitted. Successful claims combine proof of the diagnosis, documentation of military exposure to Agent Orange, and a well-supported medical opinion thoroughly explaining the connection between the two with supporting research study data.

Specific evidence to support a strong claim includes:

• Pathology reports and biopsy results confirming esophageal cancer and identifying the specific type, such as adenocarcinoma or squamous cell carcinoma.
• Cancer treatment records showing surgery, chemotherapy, radiation therapy, cancer staging, and ongoing complications.
• Documentation of residuals such as swallowing problems (dysphagia), feeding tube use, esophageal stents, repeated dilation procedures or significant weight loss.
• Military records establishing service in Vietnam, near the Korean DMZ, or another qualifying herbicide exposure location under 38 C.F.R. § 3.307(a)(6).
• Agent Orange Registry records, unit histories, or other evidence supporting exposure when military service records are incomplete or disputed.
• A detailed nexus letter from a qualified medical provider stating that the esophageal cancer is “at least as likely as not” linked with Agent Orange exposure or a service-connected condition (such as hypertension) that caused or contributed to the cancer
• A medical opinion that addresses other possible risk factors, such as smoking, alcohol use, GERD, or Barrett’s esophagus, and explains why Agent Orange exposure remains the most likely factor
• Personal statements describing exposure circumstances, symptom history, and the effects of esophageal cancer on daily life
• Statements from family members, friends, or fellow service members (buddy statements) confirming symptoms, treatment effects, swallowing difficulties, weight changes, or other observable signs or limitations

Why Are These Claims Denied and What Can Veterans Do Next?

A denial does not automatically end an esophageal cancer claim. Many unfavorable decisions result from missing records, an unsupported medical opinion, or filing under the wrong legal theory. In many situations, additional evidence can address these problems and support a new review.

Common Denials and Remedies

Esophageal cancer Agent Orange claims denials may stem from a claim mistakenly filed as presumptive (esophageal cancer is not an Agent Orange presumptive condition), a weak or boilerplate nexus, lack of documentation (such as when in-service exposure is not well documented).

Claim Mistake	Denial Reason	Potential Solution
Use of the wrong service-connection pathway	Esophageal cancer filed as Agent Orange presumptive claims. Because esophageal cancer is not on the presumptive service connected disease list, the VA may deny the claim without considering other options.	Depending on the veteran’s history, a direct service connection claim under supported by a detailed private nexus opinion and relevant medical research (or) a secondary service connection claim under if the cancer is linked to an already service-connected condition such as GERD, Barrett’s esophagus, or hypertension, (or) a PACT Act presumptive claim may be an effective remedy.
A weak or unsupported medical nexus opinion	VA examiners sometimes conclude that the cancer is not related to military service.	A detailed private medical opinion stating that the Agent Orange exposure or primary service-connected condition “more likely than not” caused or contributed to the cancer may address the weaknesses in the VA examiner’s findings.
Lack of documentation of military exposure	The VA may deny benefits when service records do not clearly place the veteran in a recognized exposure area.	Additional personnel records, unit histories, Agent Orange Registry records, or evidence from expanded PACT Act locations may help establish exposure.

Other claims have problems when residual symptoms are not fully documented or properly evaluated during the six-month review period following treatment. With a lack of clear medical evidence showing ongoing complications, the VA may reduce the temporary 100% rating without adequately considering the long-term effects of the cancer and its treatment.

What’s the Next Step?

• Refile as a Supplemental Claim with new, relevant supporting evidence such as a stronger nexus letter or additional service records.
• Request a Higher-Level Review by a senior VA adjudicator when the denial is thought to involve a factual or legal error.
• Appeal to the Board of Veterans’ Appeals, requesting a review by a Veterans Law Judge.

We’ll help choose the right path

Veterans generally have one year from the decision date to appeal while preserving the original effective date and potential back pay. New supporting evidence can include a private nexus letter, updated medical records, additional military records, or statements describing toxic exposures during service.